Myeloproliferative Disorder

Eileen Scigliano, MD

Mount Sinai School of Medicine, New York, NY

Copyright of the American Society of Hematology, 2006. ISSN: 1931-6860.

This case was reviewed and updated in March 2013 by Dr. Marc J. Kahn and members of the Teaching Cases Subcommittee.

VII. TEACHING POINTS

Comparison of CML and Reactive Granulocytosis
  Chronic Myelogenous Leukemia Reactive Granulocytosis

Pathophysiology

Clonal, autonomous proliferation of hematopoietic cells

Cytokine-induced increase in bone marrow production, release and demargination of granulocytes, secondary to infection, inflammation or malignancy

Clinical features

Patient often asymptomatic;
splenomegaly

Signs of infection, inflammation or malignancy

CBC

Granulocytosis with left shift; thrombocytosis;
basophilia

Granulocytosis with left shift;
thrombocytosis (rarely > 1,000/µL)

Cytogenetic studies

Philadelphia chromosome present

Normal

Molecular studies

Chimeric BCR-ABL gene present by FISH and PCR analysis

Normal

Treatment

Imatinib mesylate
Allogeneic stem cell transplant

Treat underlying cause

 

View Bibliography

Have a question or comment about the ASH Teaching Cases? Please e-mail webmaster@hematology.org.